본문 바로가기
KERD
논문KCI 등재

Sepsis-induced cardiac dysfunction: a review of pathophysiology

김도완|정인석|최인수|조화진|이교선|Habimana Reverien
대한중환자의학회 (The Korean Society Of Critical Care Medicine)|2020.05|Acute and Critical Care|제35권 제2호|pp. 57-66|DOI 10.4266/acc.2020.00248

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

mitochondriaheartpathophysiologysepsis

초록

It is well known that cardiac dysfunction in sepsis is associated with significantly increased mortality. The pathophysiology of sepsis-induced cardiac dysfunction can be summarized as involving impaired myocardial circulation, direct myocardial depression, and mitochondrial dysfunction. Impaired blood flow to the myocardium is associated with microvascular dysfunction, impaired endothelium, and ventriculo-arterial uncoupling. The mechanisms behind direct myocardial depression consist of downregulation of β-adrenoceptors and several myocardial suppressants (such as cytokine and nitric oxide). Recent research has highlighted that mitochondrial dysfunction, which results in energy depletion, is a major factor in sepsis-induced cardiac dysfunction. Therefore, the authors summarize the pathophysiological process of cardiac dysfunction in sepsis based on the results of recent studies.

Abstract

It is well known that cardiac dysfunction in sepsis is associated with significantly increased mortality. The pathophysiology of sepsis-induced cardiac dysfunction can be summarized as involving impaired myocardial circulation, direct myocardial depression, and mitochondrial dysfunction. Impaired blood flow to the myocardium is associated with microvascular dysfunction, impaired endothelium, and ventriculo-arterial uncoupling. The mechanisms behind direct myocardial depression consist of downregulation of β-adrenoceptors and several myocardial suppressants (such as cytokine and nitric oxide). Recent research has highlighted that mitochondrial dysfunction, which results in energy depletion, is a major factor in sepsis-induced cardiac dysfunction. Therefore, the authors summarize the pathophysiological process of cardiac dysfunction in sepsis based on the results of recent studies.

참고문헌 (67)

  1. Vieillard-Baron A, "Septic cardiomyopathy", Ann Intensive Care, 1, pp.6~ (2011)
  2. Hotchkiss RS, "The pathophysiology and treatment of sepsis", N Engl J Med, 348, pp.138~150 (2003)
  3. Geri G, "Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters : a post hoc analysis", Intensive Care Med, 45, pp.657~667 (2019)
  4. Fernandes CJ Jr, "Myocardial dysfunction in sepsis : a large, unsolved puzzle", Crit Care Res Pract, 2012, pp.896430~ (2012)
  5. L’Heureux M, "Sepsis-induced cardiomyopathy : a comprehensive review", Curr Cardiol Rep, 22, pp.35~ (2020)
  6. Pulido JN, "Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock", Mayo Clin Proc, 87, pp.620~628 (2012)
  7. Muller-Werdan U, "Septic cardiomyopathy: a not yet discovered cardiomyopathy?", Exp Clin Cardiol, 11, pp.226~236 (2006)
  8. Hoesel LM, "Complement-related molecular events in sepsis leading to heart failure", Mol Immunol, 44, pp.95~102 (2007)
  9. Parker MM, "Responses of left ventricular function in survivors and nonsurvivors of septic shock", J Crit Care, 4, pp.19~25 (1989)
  10. Poelaert J, "Left ventricular systolic and diastolic function in septic shock", Intensive Care Med, 23, pp.553~560 (1997)
  11. Parker MM, "Profound but reversible myocardial depression in patients with septic shock", Ann Intern Med, 100, pp.483~490 (1984)
  12. Parker MM, "Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans", Chest, 97, pp.126~131 (1990)
  13. Akira S, "Pathogen recognition and innate immunity", Cell, 124, pp.783~801 (2006)
  14. Raeburn CD, "Cytokines for surgeons", Am J Surg, 183, pp.268~273 (2002)
  15. Levy RJ, "Evidence of myocardial hibernation in the septic heart", Crit Care Med, 33, pp.2752~2756 (2005)
  16. Antonucci E, "Myocardial depression in sepsis : from pathogenesis to clinical manifestations and treatment", J Crit Care, 29, pp.500~511 (2014)
  17. Kakihana Y, "Sepsis-induced myocardial dysfunction : pathophysiology and management", J Intensive Care, 4, pp.22~ (2016)
  18. Kumar A, "Myocardial dysfunction in septic shock. Part II. Role of cytokines and nitric oxide", J Cardiothorac Vasc Anesth, 15, pp.485~511 (2001)
  19. Pathan N, "Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock", Lancet, 363, pp.203~209 (2004)
  20. Loppnow H, "The interleukin-1and interleukin-1 converting enzyme families in the cardiovascular system", Eur Cytokine Netw, 9, pp.675~680 (1998)
  21. Kelly RA, "Nitric oxide and cardiac function", Circ Res, 79, pp.363~380 (1996)
  22. Francis SE, "Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy", J Mol Cell Cardiol, 30, pp.215~223 (1998)
  23. Opal SM, "Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group", Crit Care Med, 25, pp.1115~1124 (1997)
  24. Müller-Werdan U, "Immune modulation by catecholamines:a potential mechanism of cytokine release in heart failure?", Herz, 25, pp.271~273 (2000)
  25. Geppert A, "Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6", Crit Care Med, 30, pp.1987~1994 (2002)
  26. Rudiger A, "Mechanisms of sepsis-induced cardiac dysfunction", Crit Care Med, 35, pp.1599~1608 (2007)
  27. Zanotti-Cavazzoni SL, "Cardiac dysfunction in severe sepsis and septic shock", Curr Opin Crit Care, 15, pp.392~397 (2009)
  28. Crouser ED, "Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia", Crit Care Med, 32, pp.478~488 (2004)
  29. Memiş D, "Effects of lornoxicam on the physiology of severe sepsis", Crit Care, 8, pp.R474~R482 (2004)
  30. Konrad D, "Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock", Crit Care Med, 32, pp.1192~1199 (2004)
  31. Raeburn CD, "ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation", Am J Physiol Regul Integr Comp Physiol, 283, pp.R477~R486 (2002)
  32. Raeburn CD, "Vascular cell adhesion molecule : 1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction", Surgery, 130, pp.319~325 (2001)
  33. Niederbichler AD, "An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction", J Exp Med, 203, pp.53~61 (2006)
  34. Alhamdi Y, "Circulating histones are major mediators of cardiac injury in patients with sepsis", Crit Care Med, 43, pp.2094~2103 (2015)
  35. VanPatten S, "High mobility group box-1(HMGb1) : current wisdom and advancement as a potential drug target", J Med Chem, 61, pp.5093~5107 (2018)
  36. Court O, "Clinical review : myocardial depression in sepsis and septic shock", Crit Care, 6, pp.500~508 (2002)
  37. Witthaut R, "Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock : impact of interleukin-6and sepsis-associated left ventricular dysfunction", Intensive Care Med, 29, pp.1696~1702 (2003)
  38. Grandel U, "Mechanisms of cardiac depression caused by lipoteichoic acids from Staphylococcus aureus in isolated rat hearts", Circulation, 112, pp.691~698 (2005)
  39. Jang DH, "Measurement of mitochondrial respiration and motility in acute care : sepsis, trauma, and poisoning", J Intensive Care Med, 32, pp.86~94 (2017)
  40. Carré JE, "Cellular energetic metabolism in sepsis : the need for a systems approach", Biochim Biophys Acta, 1777, pp.763~771 (2008)
  41. Brealey D, "Association between mitochondrial dysfunction and severity and outcome of septic shock", Lancet, 360, pp.219~223 (2002)
  42. Potz BA, "Endothelial ROS and impaired myocardial oxygen consumption in sepsis-induced cardiac dysfunction", J Intensive Crit Care, 2, pp.20~ (2016)
  43. Larsen FJ, "Regulation of mitochondrial function and energetics by reactive nitrogen oxides", Free Radic Biol Med, 53, pp.1919~1928 (2012)
  44. Crouser ED, "Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome", Mitochondrion, 4, pp.729~741 (2004)
  45. Kayali R, "Effect of gender on main clinical chemistry parameters in aged rats", Curr Aging Sci, 2, pp.67~71 (2009)
  46. Galley HF, "Oxidative stress and mitochondrial dysfunction in sepsis", Br J Anaesth, 107, pp.57~64 (2011)
  47. Lowes DA, "Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis", Br J Anaesth, 110, pp.472~480 (2013)
  48. Bernardi P, "The mitochondrial permeability transition pore : molecular nature and role as a target in cardioprotection", J Mol Cell Cardiol, 78, pp.100~106 (2015)
  49. Duncan DJ, "TNFalpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes", Cell Calcium, 47, pp.378~386 (2010)
  50. Hassoun SM, "Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction", Crit Care Med, 36, pp.2590~2596 (2008)
  51. Shanmuganathan S, "Mitochondrial permeability transition pore as a target for cardioprotection in the human heart", Am J Physiol Heart Circ Physiol, 289, pp.H237~H242 (2005)
  52. Smeding L, "Structural changes of the heart during severe sepsis or septic shock", Shock, 37, pp.449~456 (2012)
  53. Finkel MS, "Negative inotropic effects of cytokines on the heart mediated by nitric oxide", Science, 257, pp.387~389 (1992)
  54. Wu LL, "Calcium uptake by sarcoplasmic reticulum is impaired during the hypodynamic phase of sepsis in the rat heart", Shock, 15, pp.49~55 (2001)
  55. Galluzzi L, "Mitochondrial control of cellular life, stress, and death", Circ Res, 111, pp.1198~1207 (2012)
  56. Nunnari J, "Mitochondria : in sickness and in health", Cell, 148, pp.1145~1159 (2012)
  57. Harrington JS, "Mitochondrial DNA in Sepsis", Curr Opin Crit Care, 23, pp.284~290 (2017)
  58. Nakahira K, "Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome", Nat Immunol, 12, pp.222~230 (2011)
  59. Nakahira K, "Circulating mitochondrial DNA in patients in the ICU as a marker of mortality : derivation and validation", PLoS Med, 10, pp.e1001577~ (2013)
  60. Bhagirath VC, "Comparison of the proinflammatory and procoagulant properties of nuclear, mitochondrial, and bacterial DNA", Shock, 44, pp.265~271 (2015)
  61. Sánchez-Villamil JP, "Cardiac-specific overexpression of thioredoxin 1 attenuates mitochondrial and myocardial dysfunction in septic mice", Int J Biochem Cell Biol, 81(Pt B), pp.323~334 (2016)
  62. Liesa M, "Mitochondrial dynamics in mammalian health and disease", Physiol Rev, 89, pp.799~845 (2009)
  63. Zhan M, "Mitochondrial dynamics : regulatory mechanisms and emerging role in renal pathophysiology", Kidney Int, 83, pp.568~581 (2013)
  64. Wu Y, "Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure", J Mol Med(Berl), 97, pp.451~462 (2019)
  65. Singer M, "The role of mitochondrial dysfunction in sepsis-induced multi-organ failure", Virulence, 5, pp.66~72 (2014)
  66. Gunst J, "Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness", Crit Care Med, 41, pp.182~194 (2013)
  67. Rocha M, "Mitochondrial dysfunction and antioxidant therapy in sepsis", Infect Disord Drug Targets, 12, pp.161~178 (2012)

관련 논문AI추천

Sepsis-induced cardiomyopathy is associated with higher mortality rates in patients with sepsisAanchal Gupta, Adarsh Katamreddy, Anika Sasidharan Nair, Ankita Krishnan, Ankit Kushwaha, Balaram Krishna J Hanumanthu, Harmeen Goraya, Jason S Gilbert, Jee Young You, Joaquin Morante, Leonidas Palaidimos, Marzio Napolitano, Mengyang Sun, Obiageli Lynda Offor, Perminder Gulani, Robert T. Faillace, Seema S. Tekwani, Suchita Mehta대한중환자의학회 · Acute and Critical Care2021 · 제36권 제3호Predictors and outcomes of sepsis-induced cardiomyopathy in critically ill patients장준, 강영애, 김송이, 김영삼, 김은영, 박무석, 송명진, 이상훈, 임아영, 정경수, 정지예대한중환자의학회 · Acute and Critical Care2020 · 제35권 제2호Role of Mitochondrial Oxidative Stress in SepsisCuk-Seong Kim, Harsha Nagar, Shuyu Piao대한중환자의학회 · Acute and Critical Care2018 · 제33권 제2호How Do I Integrate Hemodynamic Variables When Managing Septic Shock?Jean-Louis Teboul, Olfa Hamzaoui대한중환자의학회 · Acute and Critical Care2016 · 제31권 제4호Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis박대원, Jaroslaw W Zmijewski대한감염학회 · Infection and Chemotherapy2017 · 제49권 제1호Impact of tadalafil on cardiovascular and organ dysfunction induced by experimental sepsisDaniel Fernandes, Gabrielle Delfrate, Gustavo Ferreira Alves, Junior Garcia Oliveira, Lucas Braga Albino, Marcelo Almeida Nakashima대한중환자의학회 · Acute and Critical Care2025 · 제40권 제1호

이 간행물의 다른 논문 (10건)

Predictors and outcomes of sepsis-induced cardiomyopathy in critically ill patients박무석, 이상훈, 김송이, 임아영, 김은영, 정경수, 김영삼, 정지예, 강영애, 장준, 송명진pp. 67-76Effectiveness of a daytime rapid response system in hospitalized surgical ward patients이한나, 이현주, 김설희, 오승영, 양은진, 이상민, 류호걸, 이진우pp. 77-86Effects of the presence of a pediatric intensivist on treatment in the pediatric intensive care unit권정은, 노다은, 김여향pp. 87-92Measurement of mean systemic filling pressure after severe hemorrhagic shock in swine anesthetized with propofol-based total intravenous anesthesia: implications for vasopressor-free resuscitationKoutsovasilis Anastasios, Xanthos Theodoros, Laou Eleni, Papalois Apostolos, Chalkias Athanasiospp. 93-101Inclusion of lactate level measured upon emergency room arrival in trauma outcome prediction models improves mortality prediction: a retrospective, single-center study윤덕용, 문종환, 정경원, 황경진pp. 102-109
원문 보기